Published in Am J Surg on July 01, 1993
Transforming growth factor-beta 1 modulates beta 1 and beta 5 integrin receptors and induces the de novo expression of the alpha v beta 6 heterodimer in normal human keratinocytes: implications for wound healing. J Cell Biol (1995) 1.85
Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice. Mol Cell Biol (2000) 1.65
Determination of endogenous cytokines in chronic wounds. Ann Surg (1994) 1.17
Wound healing of cutaneous sulfur mustard injuries: strategies for the development of improved therapies. J Burns Wounds (2005) 1.11
Growth factor staining patterns in the pig retina following retinal laser photocoagulation. Br J Ophthalmol (1999) 1.08
Characterization of engineered tissue development under biaxial stretch using nonlinear optical microscopy. Tissue Eng Part A (2009) 1.06
Enhanced skin wound healing by a sustained release of growth factors contained in platelet-rich plasma. Exp Mol Med (2011) 1.00
Platelet-rich plasma combined with skin substitute for chronic wound healing: a case report. J Extra Corpor Technol (2006) 0.98
A review of becaplermin gel in the treatment of diabetic neuropathic foot ulcers. Biologics (2008) 0.96
Tissue repair processes in healing chronic pressure ulcers treated with recombinant platelet-derived growth factor BB. Am J Pathol (1994) 0.93
Sequential cytokine therapy for pressure ulcers: clinical and mechanistic response. Ann Surg (2000) 0.93
TGF-beta1 regulates TGF-beta1 and FGF-2 mRNA expression during fibroblast wound healing. Mol Pathol (2002) 0.89
The role of epidermal growth factor in the healing tympanic membrane following perforation in rats. J Mol Histol (2010) 0.88
Application of autologous derived-platelet rich plasma gel in the treatment of chronic wound ulcer: diabetic foot ulcer. J Extra Corpor Technol (2010) 0.87
Local biochemical and morphological differences in human Achilles tendinopathy: a case control study. BMC Musculoskelet Disord (2012) 0.83
Surgical stress inhibits the growth of fibroblasts through the elevation of plasma catecholamine and cortisol concentrations. Surg Today (1997) 0.80
Biologic therapeutics and molecular profiling to optimize wound healing. Gynecol Oncol (2008) 0.78
The α4β1 integrin and the EDA domain of fibronectin regulate a profibrotic phenotype in dermal fibroblasts. Matrix Biol (2014) 0.77
Sequential Change of Wound Calculated by Image Analysis Using a Color Patch Method during a Secondary Intention Healing. PLoS One (2016) 0.75
Increased interleukin 1 and tumor necrosis factor alpha levels after thyroid surgery. Ulus Cerrahi Derg (2014) 0.75
Diabetes mellitus and burns. Part I-basic science and implications for management. Int J Burns Trauma (2015) 0.75
Platelet-Rich Plasma-Loaded Poly(d,l-lactide)-Poly(ethylene glycol)-Poly(d,l-lactide) Hydrogel Dressing Promotes Full-Thickness Skin Wound Healing in a Rodent Model. Int J Mol Sci (2016) 0.75
Development of Stabilized Growth Factor-Loaded Hyaluronate- Collagen Dressing (HCD) matrix for impaired wound healing. Biomater Res (2016) 0.75
Molecular Aspects of Wound Healing and the Rise of Venous Leg Ulceration: Omics Approaches to Enhance Knowledge and Aid Diagnostic Discovery. Clin Biochem Rev (2017) 0.75
Intradiscal platelet-rich plasma (PRP) injections for discogenic low back pain: an update. Int Orthop (2016) 0.75
Enhancement of wound healing by topical treatment with epidermal growth factor. N Engl J Med (1989) 3.39
Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med (1997) 2.88
Pterygia pathogenesis: corneal invasion by matrix metalloproteinase expressing altered limbal epithelial basal cells. Arch Ophthalmol (2001) 2.24
Epithelial wound healing enhanced by transforming growth factor-alpha and vaccinia growth factor. Science (1987) 2.24
Growth factors and wound healing: biochemical properties of growth factors and their receptors. Am J Surg (1993) 2.00
Enhancement of epidermal regeneration by biosynthetic epidermal growth factor. J Exp Med (1986) 1.72
Epidermal growth factor, transforming growth factor alpha, transforming growth factor beta, acidic fibroblast growth factor, basic fibroblast growth factor, and interleukin-1 proteins in the cornea. Exp Eye Res (1994) 1.46
Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels. Cancer Res (1984) 1.45
Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen (1996) 1.37
Preparation of functional smooth muscle cells from the rabbit aorta. J Exp Med (1978) 1.33
Biochemical analysis of acute and chronic wound environments. Wound Repair Regen (2006) 1.32
Guinea pig pancreatic acini prepared with purified collagenase. Exp Cell Res (1980) 1.28
Effect of epidermal growth factor, hepatocyte growth factor, and keratinocyte growth factor, on proliferation, motility and differentiation of human corneal epithelial cells. Exp Eye Res (1994) 1.27
TGF-beta1, -beta2, and -beta3 in vitro: biphasic effects on Tenon's fibroblast contraction, proliferation, and migration. Invest Ophthalmol Vis Sci (2000) 1.25
Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture. Cancer Res (1984) 1.19
Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome. Gene Ther (2003) 1.17
Single exposures to antiproliferatives: long-term effects on ocular fibroblast wound-healing behavior. Invest Ophthalmol Vis Sci (1997) 1.13
Acceleration of tensile strength of incisions treated with EGF and TGF-beta. Ann Surg (1988) 1.05
Different tropism of adenoviruses and adeno-associated viruses to corneal cells: implications for corneal gene therapy. Mol Vis (2008) 1.05
Age-related differences in the temporal and spatial regulation of matrix metalloproteinases (MMPs) in normal skin and acute cutaneous wounds of healthy humans. Cell Tissue Res (1997) 1.05
Causes and effects of the chronic inflammation in venous leg ulcers. Acta Derm Venereol Suppl (Stockh) (2000) 1.04
Effect of growth factors with dexamethasone on healing of rabbit corneal stromal incisions. Exp Eye Res (1985) 1.00
Biosynthetic human EGF accelerates healing of Neodecadron-treated primate corneas. Invest Ophthalmol Vis Sci (1985) 0.97
Molecular and mechanistic validation of delayed healing rat wounds as a model for human chronic wounds. Wound Repair Regen (2000) 0.97
Binding sites for epidermal growth factor in human uterine tissues and leiomyomas. J Clin Endocrinol Metab (1984) 0.95
Effects of epidermal growth factor, fibroblast growth factor, and transforming growth factor-beta on corneal cell chemotaxis. Invest Ophthalmol Vis Sci (1992) 0.94
Amniotic fluid matrix metalloproteinase-9 levels in women with preterm labor and suspected intra-amniotic infection. Obstet Gynecol (1999) 0.94
Competitive RNA templates for detection and quantitation of growth factors, cytokines, extracellular matrix components and matrix metalloproteinases by RT-PCR. Biotechniques (1996) 0.92
Biological activity of an angiotensin II--ferritin conjugate on rabbit aortic smooth muscle cells. Biochemistry (1981) 0.88
Growth factors and corneal endothelial cells: I. Stimulation of bovine corneal endothelial cell DNA synthesis by defined growth factors. Cornea (1992) 0.88
Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy. J Clin Endocrinol Metab (1996) 0.88
Keratinocyte collagenase-1 expression requires an epidermal growth factor receptor autocrine mechanism. J Biol Chem (1999) 0.87
Competition of delta 9-tetrahydrocannabinol with estrogen in rat uterine estrogen receptor binding. Science (1977) 0.86
Transforming growth factor alpha and its receptor in neural retina. Invest Ophthalmol Vis Sci (1989) 0.85
Measurement of alpha-lactalbumin in serum and mammary tumors of rats by radioimmunoassay. Cancer Res (1977) 0.85
Enhanced short-term plasmid transfection of filtration surgery tissues. Invest Ophthalmol Vis Sci (2000) 0.85
Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumours. Int J Cancer (1995) 0.85
Inhibition of proteases in Pseudomonas otitis media in chinchillas. Otolaryngol Head Neck Surg (1996) 0.85
Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: a mechanism for gonadotrophin releasing hormone agonist-induced tumour regression. Mol Hum Reprod (1997) 0.84
Reversal of Adriamycin-impaired wound healing by transforming growth factor-beta. Surg Gynecol Obstet (1989) 0.84
Molecular therapy in ocular wound healing. Br J Ophthalmol (1999) 0.84
Absorption of epidermal growth factor occurs through the gastrointestinal tract and oral cavity in adult rats. Am J Physiol (1995) 0.84
Effect of healing on the expression of transforming growth factor beta(s) and their receptors in chronic venous leg ulcers. J Invest Dermatol (2001) 0.83
Binding sites for epidermal growth factor in human fetal membranes. J Clin Endocrinol Metab (1984) 0.83
Detection of epidermal growth factor and transforming growth factor alpha protein in meningiomas and other tumors of the central nervous system in human beings. Surg Gynecol Obstet (1993) 0.83
Regulation of small intestinal glutamine transport by epidermal growth factor. Surgery (1993) 0.83
Inhibition of pseudomonal ulceration in rabbit corneas by a synthetic matrix metalloproteinase inhibitor. Invest Ophthalmol Vis Sci (1996) 0.82
alpha-Lactalbumin levels in human mammary tumors, sera, and mammary cell culture lines. Cancer Res (1977) 0.82
Levels of epidermal growth factor binding in third-trimester and term human placentas: elevated binding in term placentas of male fetuses. Am J Obstet Gynecol (1987) 0.81
Inhibition of transforming growth factor alpha stimulation of human squamous cell carcinoma of the head and neck with anti-TGF-alpha antibodies and tyrphostin. Ann Surg Oncol (1997) 0.81
Detection of transforming growth factor-alpha messenger RNA and protein in human corneal epithelial cells. Invest Ophthalmol Vis Sci (1992) 0.81
Transforming and epidermal growth factors in degenerated intervertebral discs. J Bone Joint Surg Br (1999) 0.81
Increased binding of epidermal growth factor at preimplantation sites in mouse uteri. Endocrinology (1989) 0.81
Effect of topical recombinant TGF-beta on healing of partial thickness injuries. J Surg Res (1991) 0.80
Rapid purification of radioiodinated peptides with Sep-Pak reversed phase cartridges and HPLC. Int J Pept Protein Res (1984) 0.80
Amniotic fluid concentrations of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during pregnancy and labor. Am J Obstet Gynecol (2001) 0.80
Expression of alpha-smooth muscle actin, TGF-beta 1 and TGF-beta type II receptor during connective tissue contraction. In Vitro Cell Dev Biol Anim (1997) 0.80
Changes in the expression of extracellular matrix (ECM) and matrix metalloproteinases (MMP) of proliferating rat parotid acinar cells. J Dent Res (1998) 0.80
Extracellular-matrix gene expression during mouse submandibular gland development. Arch Oral Biol (1997) 0.80
Analysis of protease activity in human otitis media. Otolaryngol Head Neck Surg (1998) 0.79
Intraoperative and post operative treatment with 5-fluorouracil and mitomycin-c: long term effects in vivo on subconjunctival and scleral fibroblasts. Int Ophthalmol (1992) 0.79
Epidermal growth factor binding and action on tympanic membranes. Ann Otol Rhinol Laryngol (1990) 0.79
Ham's F-10 constituted with tap water supports mouse conceptus development in vitro. J In Vitro Fert Embryo Transf (1987) 0.78
Growth factors and corneal endothelial cells: II. Characterization of epidermal growth factor receptor from bovine corneal endothelial cells. Cornea (1992) 0.78
Elevation of transforming growth factor alpha in cat aqueous humor after corneal endothelial injury. Invest Ophthalmol Vis Sci (1994) 0.78
Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors. Ann Surg (1995) 0.77
Growth factors in human tear fluid and in lacrimal glands. Adv Exp Med Biol (1994) 0.77
Topography of human placental receptors for epidermal growth factor. J Biol Chem (1985) 0.76
Human ageing impairs injury-induced in vivo expression of tissue inhibitor of matrix metalloproteinases (TIMP)-1 and -2 proteins and mRNA. J Pathol (1997) 0.76
Characterization of the synthesis and secretion of transforming growth factor-alpha from salivary glands and saliva. Endocrinology (1994) 0.76
Profiles of matrix metalloproteinase activity in equine tear fluid during corneal healing in 10 horses with ulcerative keratitis. Vet Ophthalmol (2004) 0.76
Progress in burn therapy: skin banking and epidermal culture. J Ky Med Assoc (1985) 0.75
Corneal wound healing in laser in situ keratomileusis. Int Ophthalmol Clin (1996) 0.75
Effects of transforming growth factor-beta1 on extracellular matrix gene expression by human fibroblasts from a laryngeal stenotic lesion. Wound Repair Regen (2006) 0.75
Epidermal growth factor accelerates connective tissue wound healing in the perforated rat mesentery. J Surg Res (1992) 0.75
Cellular distribution of epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor in fascia and peritoneum during healing in the rat: an autoradiographic and immunohistochemical study. Wound Repair Regen (1993) 0.75
The presence of epidermal growth factor binding sites in the intracellular organelles of term human placenta. J Cell Sci (1986) 0.75
Epidermal growth factor in urine of nonpregnant women and pregnant women throughout pregnancy and at delivery. J Clin Endocrinol Metab (1988) 0.75
Effects of long-term dietary choline and phosphatidylcholine administration on muscarinic receptors in aged mouse brain. Neurol Res (1988) 0.75
Messenger RNA levels for genes involved in extracellular matrix from human corneal scrapings before and after photorefractive keratectomy. Acta Ophthalmol Scand (1998) 0.75
Stimulation of protracted connective tissue repair in normal mice by transforming growth factor beta 1. Scand J Plast Reconstr Surg Hand Surg (1996) 0.75
Alpha-smooth muscle actin expression in rat and mouse mesenteric wounds after transforming growth factor-beta1 treatment. Wound Repair Regen (2006) 0.75
TGF-alpha protein and receptor localization in laryngotracheal tissue. Otolaryngol Head Neck Surg (1993) 0.75
Transforming growth factor-beta enhances connective tissue repair in perforated rat mesentery but not peritoneal macrophage chemotaxis. Wound Repair Regen (1993) 0.75
Intrauterine proximity to male fetuses predetermines level of epidermal growth factor in submandibular glands of adult female mice. Endocrinology (1984) 0.75